Organization
Acasti Pharma, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Acasti Pharma, Inc.
... & BIORESOURCES RECENT BUYING & SELLING: October 04: Neptune Technologies & Bioresources: Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest under ...
... million and impairment loss on inventories of $1.7 million. Consolidated Results (including Acasti Pharma) Second Quarter Financial Results versus $0.9 million in the prior year. ...
... million and impairment loss on inventories of $1.7 million. Consolidated Results (including Acasti Pharma) Second Quarter Financial Results -- Consolidated revenues totalled $6.8 million for ...
... CANADIAN MONTHLY STOCK REPORT Acasti Pharma (TSXV:ACST), Canada's 30th largest Biotechnology company by market cap, has dropped 4.0c ...
... EDT ORIGINAL ANNOUNCEMENT [Text] LAVAL, QUEBEC--(Marketwired - Oct. 4, 2017) - Acasti Pharma Inc. ("Acasti" or the "Corporation") (NASDAQ:ACST)(TSX VENTURE:ACST) announces that in accordance with ...
... LAVAL, QUEBEC--(Marketwired - Oct. 4, 2017) - Acasti Pharma Inc. ("Acasti" or the "Corporation") (NASDAQ:ACST)(TSX VENTURE:ACST) announces that in accordance with ...
... Acasti Pharma Inc. ("Acasti" or the "Corporation") (NASDAQ:ACST)(TSX VENTURE:ACST), today announced the grant of ...
... MONTREAL, QUEBEC--(Marketwired - Aug. 16, 2017) - Acasti Pharma Inc. (NASDAQ:ACST)(TSX VENTURE:ACST), a biopharmaceutical innovator focused on the research, development and ...
... decrease partially offset by the decrease in SG&A expenses. Consolidated Results (including Acasti Pharma) First Quarter Financial Results versus $1.1 million in the prior year. ...
... decrease partially offset by the decrease in SG&A expenses. Consolidated Results (including Acasti Pharma) First Quarter Financial Results -- Consolidated revenues totalled $6.5 million for ...
... decrease partially offset by the decrease in SG&A expenses. Consolidated Results (including Acasti Pharma) First Quarter Financial Results On a consolidated basis, the current quarter ...
... will remain actively involved in this sector via our investment in Acasti Pharma Inc. and also through finished form soft gel capsules from our Solutions ...
... Acasti Pharma Inc. ("Acasti" or the "Corporation") (NASDAQ:ACST)(TSX VENTURE:ACST) announces that in accordance with ...
... LAVAL, QUEBEC -- (Marketwired) -- 06/14/17 -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (NASDAQ:ACST)(TSX VENTURE:ACST), today announced the grant of ...
... Acasti Pharma Inc. has announced that it will present results from the CaPre, indicated ...
... and Adjusted EBITDA also included unallocated production overhead costs. Consolidated Results (including Acasti Pharma) Fourth Quarter Financial Results versus ($0.5) million in the prior year. ...
... Acasti Pharma Inc. has announced the achievement of a corporate milestone by manufacturing the ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤